IMARC Releases report on Indian Diabetes Market Outlook: 2010-2015
06/12/2010

IMARC has finally released its much awaited report on the Indian Diabetes Market Outook for 2010-2015.

India promises to be amongst the most lucrative Diabetes Markets in the World. Numerous factors such as the world鈥檚 largest diabetes patient pool, the success of newly launched innovative drugs, increasing diagnosis and drug treated rates, and a rapidly growing market are driving all major pharmacutical manufacturers in this Market.

Online PR News – 12-June-2010 – – IMARC has finally released its much awaited report on the Indian Diabetes Market Outook for 2010-2015.

India promises to be amongst the most lucrative Diabetes Markets in the World. Numerous factors such as the world鈥檚 largest diabetes patient pool, the success of newly launched innovative drugs, increasing diagnosis and drug treated rates, and a rapidly growing market are driving all major pharma manufacturers in this Market.

路 A growing drug treated population coupled with the launch of several new agents is expected to drive the Indian diabetes market to US$1.4 Billion by 2015

路 In 2009, the Market for Non-insulin Antidiabetics was worth US$ 306 Million. Growth in this market in the next five years will be driven by the strong uptake of novel drugs such as DPP-IV inhibitors and GLP-1 analogues

路 Although the market for Non-insulin antidiabetics is highly genericized, the success of Merck鈥檚 Januvia (Sitagliptin) Suggests that there exists a large segment in the Indian population that can afford highly priced but innovative drugs

路 The Insulin market in India is presently dominated by intermediate + rapid acting Insulin鈥檚. The popularity of long acting Insulin is, however, rapidly increasing.

路 Unlike the Non-Insulin antidiabetics Market, the market for Insulin is highly concentrated with the top three players accounting for 88% of the total market

.路 IMARC Expects the Insulin market to grow at a CAGR of 25% between 2010-2015 reaching sales over US$ 448 Million by 2015 Forecasts: The report provides forecasts on:

路 Total Number of Diabetes patients
路 Diagnosis and treatment rates in India
路 Total Diabetes Market
路 Total Non-insulin diabetes Market
路 Glitazones
路 Biguanides
路 Sulphonylureas
路 Alpha-Glycosidase Inhibitors
路 DPP-IV inhibhitors
路 GLP-Agonists
路 Glinides
路 All other Non-insulin Antidiabetes classes
路 Total Insulin Market

Competitive Landscape: This section covers:

路 2005-2009 sales and market shares of top five players in the total diabetes Market
路 2005-2009 sales and market shares of top five players in the Non-Insulin diabetes Market
路 2005-2009 sales and market shares of top five players in all of the eight segments comprising the Non-insulin antidiabetes Market
路 2005-2009 sales of each drug comprising the portfolio of each of the top 5 players in all the eight segments comprising the Non-insulin antidiabetes Market
路 2005-2009 sales and market shares of top five players in the Insulin Market
路 2005-2009 sales of each drug comprising the portfolio of each of the top 5 players in the Insulin market.

Key Questions Answered in this report

路 What is the total size of the diabetes population in India and what are its characteristics?
路 What are the diagnosis and drug treatment rates for diabetes in India?
路 What are the key factors driving the growth of diabetes medications in India?
路 What is the Size and Breakup of the total Diabetes Market in India?
路 What is the Size and Breakup of the total Non-Insulin diabetes market in India?
路 What is the Size and Breakup of the total Insulin diabetes market in India?
路 Who are the key players in the Indian diabetes market and how has their performance been in the last five years?
路 What is the outlook of the Indian diabetes market in the next five years?
路 Which novel products are expected to be launched in the next five years?
路 Which therapy classes will show the highest growth in the next five years?
路 What are the road blocks in the Indian diabetes market?

The report is priced at USD 1200 for the single user PDF version. IMARC Is offering an Inaugral discount of 20% for the first 2 months. Send an email to sales@imarcgroup.com or call +91-9810441494 now and our representative will get in touch with you.